Overview

Safety Study of Elvucitabine in HIV-1 Subjects

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this 28 day study is to assess the viral kinetics and safety of elvucitabine.
Phase:
Phase 2
Details
Lead Sponsor:
Thomas Jefferson University
Treatments:
Dexelvucitabine